48,479
edits
Difference between revisions of "Liver neoplasms"
Jump to navigation
Jump to search
m
→IHC: more
m (→IHC: more) |
|||
| Line 268: | Line 268: | ||
*AFP +ve; may be neg. even if the serum AFP is elevated. | *AFP +ve; may be neg. even if the serum AFP is elevated. | ||
*CK18 +ve.<ref>AP. 28 May 2009.</ref> | *CK18 +ve.<ref>AP. 28 May 2009.</ref> | ||
*Glypican-3 +ve (cytoplasmic, granular cytoplasmic or membranous).<ref name=pmid19212669>{{Cite journal | last1 = Shirakawa | first1 = H. | last2 = Kuronuma | first2 = T. | last3 = Nishimura | first3 = Y. | last4 = Hasebe | first4 = T. | last5 = Nakano | first5 = M. | last6 = Gotohda | first6 = N. | last7 = Takahashi | first7 = S. | last8 = Nakagohri | first8 = T. | last9 = Konishi | first9 = M. | title = Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer. | journal = Int J Oncol | volume = 34 | issue = 3 | pages = 649-56 | month = Mar | year = 2009 | doi = | PMID = 19212669 | url = http://www.spandidos-publications.com/serveFile/ijo_34_3_649_PDF.pdf?type=article&article_id=ijo_34_3_649&item=PDF}}</ref> | |||
==Cholangiocarcioma== | ==Cholangiocarcioma== | ||